Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Apr 13, 2007 1:09pm
307 Views
Post# 12602901

"Live From New York it''s----------Dr. CRUZ !!

"Live From New York it''s----------Dr. CRUZ !! Like they say winer.......you snooze you lose. Phase1's for Gastrin alone were released months ago maybe years ago......they have been quoting that G1 has no Nausea or headaches for months and months ....... maybe years. It's a known fact that its not Gastrin that causes nausea and headaches its the other Factors like Glucagon Like Peptide (GLP1)!! Dr. Cruz said nothing about the GLP1-INT Phasel Data except that its just about complete. I would suggest you get your facts straight......... Have you read Dr. Andre Uddins Presentation from the mARRS Seminar last year? If you had you would see that there will be no release of Data for GLP1-INT Phasel until the Patents are Secured. Securing Patents are an ongoing necessary evil from discovery to pre-clinicals to clinicals and beyond...........Dr. Uddin also suggests no release of interim data due to the patent security issues...... I have a pdf of the presentation if you want it. Good Luck There...... thats more comprehensive..........LOL
Bullboard Posts